nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—Dacarbazine—muscle cancer	0.158	0.206	CbGbCtD
Rabeprazole—ABCG2—Dactinomycin—muscle cancer	0.148	0.193	CbGbCtD
Rabeprazole—ABCG2—Vincristine—muscle cancer	0.0914	0.119	CbGbCtD
Rabeprazole—ABCG2—Etoposide—muscle cancer	0.0838	0.109	CbGbCtD
Rabeprazole—CYP1A2—Dacarbazine—muscle cancer	0.0706	0.0918	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—muscle cancer	0.0571	0.0743	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—muscle cancer	0.0553	0.072	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—muscle cancer	0.0345	0.0449	CbGbCtD
Rabeprazole—CYP3A4—Vincristine—muscle cancer	0.0197	0.0257	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—muscle cancer	0.0194	0.0252	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—muscle cancer	0.0181	0.0235	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—muscle cancer	0.0123	0.0161	CbGbCtD
Rabeprazole—ATP4A—larynx—muscle cancer	0.00731	0.54	CbGeAlD
Rabeprazole—ATP4A—renal system—muscle cancer	0.00122	0.0904	CbGeAlD
Rabeprazole—ATP4A—head—muscle cancer	0.000819	0.0605	CbGeAlD
Rabeprazole—ATP4A—testis—muscle cancer	0.000791	0.0584	CbGeAlD
Rabeprazole—CYP1A2—renal system—muscle cancer	0.000349	0.0258	CbGeAlD
Rabeprazole—CYP1A1—renal system—muscle cancer	0.000344	0.0254	CbGeAlD
Rabeprazole—Increased appetite—Doxorubicin—muscle cancer	0.000313	0.00144	CcSEcCtD
Rabeprazole—Insomnia—Vincristine—muscle cancer	0.000311	0.00143	CcSEcCtD
Rabeprazole—CYP2C19—vagina—muscle cancer	0.00031	0.0229	CbGeAlD
Rabeprazole—Paraesthesia—Vincristine—muscle cancer	0.000309	0.00142	CcSEcCtD
Rabeprazole—CYP1A1—cardiac atrium—muscle cancer	0.000308	0.0228	CbGeAlD
Rabeprazole—Malaise—Etoposide—muscle cancer	0.000308	0.00142	CcSEcCtD
Rabeprazole—Vertigo—Etoposide—muscle cancer	0.000307	0.00141	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000306	0.00141	CcSEcCtD
Rabeprazole—Leukopenia—Etoposide—muscle cancer	0.000306	0.00141	CcSEcCtD
Rabeprazole—Body temperature increased—Dactinomycin—muscle cancer	0.000305	0.0014	CcSEcCtD
Rabeprazole—Abdominal pain—Dactinomycin—muscle cancer	0.000305	0.0014	CcSEcCtD
Rabeprazole—Loss of consciousness—Etoposide—muscle cancer	0.0003	0.00138	CcSEcCtD
Rabeprazole—Decreased appetite—Vincristine—muscle cancer	0.000299	0.00138	CcSEcCtD
Rabeprazole—Cough—Etoposide—muscle cancer	0.000298	0.00137	CcSEcCtD
Rabeprazole—Convulsion—Etoposide—muscle cancer	0.000296	0.00136	CcSEcCtD
Rabeprazole—Hyponatraemia—Doxorubicin—muscle cancer	0.000295	0.00136	CcSEcCtD
Rabeprazole—Hypertension—Etoposide—muscle cancer	0.000295	0.00136	CcSEcCtD
Rabeprazole—Constipation—Vincristine—muscle cancer	0.000294	0.00135	CcSEcCtD
Rabeprazole—Pain—Vincristine—muscle cancer	0.000294	0.00135	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000294	0.00135	CcSEcCtD
Rabeprazole—Diplopia—Doxorubicin—muscle cancer	0.000294	0.00135	CcSEcCtD
Rabeprazole—Osteoarthritis—Doxorubicin—muscle cancer	0.000294	0.00135	CcSEcCtD
Rabeprazole—Asthma—Methotrexate—muscle cancer	0.000294	0.00135	CcSEcCtD
Rabeprazole—Chest pain—Etoposide—muscle cancer	0.000291	0.00134	CcSEcCtD
Rabeprazole—Migraine—Doxorubicin—muscle cancer	0.00029	0.00133	CcSEcCtD
Rabeprazole—Pancreatitis—Methotrexate—muscle cancer	0.000288	0.00132	CcSEcCtD
Rabeprazole—Discomfort—Etoposide—muscle cancer	0.000287	0.00132	CcSEcCtD
Rabeprazole—Face oedema—Doxorubicin—muscle cancer	0.000284	0.00131	CcSEcCtD
Rabeprazole—Hypersensitivity—Dactinomycin—muscle cancer	0.000284	0.0013	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Vincristine—muscle cancer	0.000282	0.00129	CcSEcCtD
Rabeprazole—Confusional state—Etoposide—muscle cancer	0.000281	0.00129	CcSEcCtD
Rabeprazole—Pancytopenia—Methotrexate—muscle cancer	0.000279	0.00128	CcSEcCtD
Rabeprazole—Anaphylactic shock—Etoposide—muscle cancer	0.000279	0.00128	CcSEcCtD
Rabeprazole—Asthenia—Dactinomycin—muscle cancer	0.000276	0.00127	CcSEcCtD
Rabeprazole—Dysuria—Methotrexate—muscle cancer	0.000275	0.00126	CcSEcCtD
Rabeprazole—Neutropenia—Methotrexate—muscle cancer	0.000275	0.00126	CcSEcCtD
Rabeprazole—ABCG2—bone marrow—muscle cancer	0.000274	0.0203	CbGeAlD
Rabeprazole—Dehydration—Doxorubicin—muscle cancer	0.000274	0.00126	CcSEcCtD
Rabeprazole—Thrombocytopenia—Etoposide—muscle cancer	0.000273	0.00125	CcSEcCtD
Rabeprazole—Tachycardia—Etoposide—muscle cancer	0.000272	0.00125	CcSEcCtD
Rabeprazole—Abdominal pain—Vincristine—muscle cancer	0.000272	0.00125	CcSEcCtD
Rabeprazole—Body temperature increased—Vincristine—muscle cancer	0.000272	0.00125	CcSEcCtD
Rabeprazole—Liver function test abnormal—Doxorubicin—muscle cancer	0.000272	0.00125	CcSEcCtD
Rabeprazole—Erectile dysfunction—Methotrexate—muscle cancer	0.000271	0.00124	CcSEcCtD
Rabeprazole—Dry skin—Doxorubicin—muscle cancer	0.00027	0.00124	CcSEcCtD
Rabeprazole—Hyperhidrosis—Etoposide—muscle cancer	0.00027	0.00124	CcSEcCtD
Rabeprazole—Abdominal pain upper—Doxorubicin—muscle cancer	0.000269	0.00124	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.000268	0.00123	CcSEcCtD
Rabeprazole—Hypokalaemia—Doxorubicin—muscle cancer	0.000268	0.00123	CcSEcCtD
Rabeprazole—Anorexia—Etoposide—muscle cancer	0.000266	0.00122	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000265	0.00122	CcSEcCtD
Rabeprazole—Diarrhoea—Dactinomycin—muscle cancer	0.000264	0.00121	CcSEcCtD
Rabeprazole—Pneumonia—Methotrexate—muscle cancer	0.000263	0.00121	CcSEcCtD
Rabeprazole—ABCG2—vagina—muscle cancer	0.000263	0.0194	CbGeAlD
Rabeprazole—Hypotension—Etoposide—muscle cancer	0.000261	0.0012	CcSEcCtD
Rabeprazole—Gastritis—Doxorubicin—muscle cancer	0.00026	0.0012	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00026	0.00119	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00026	0.00119	CcSEcCtD
Rabeprazole—Abdominal distension—Doxorubicin—muscle cancer	0.000256	0.00118	CcSEcCtD
Rabeprazole—Stomatitis—Methotrexate—muscle cancer	0.000255	0.00117	CcSEcCtD
Rabeprazole—Conjunctivitis—Methotrexate—muscle cancer	0.000255	0.00117	CcSEcCtD
Rabeprazole—Asthma—Doxorubicin—muscle cancer	0.000254	0.00117	CcSEcCtD
Rabeprazole—Dysphagia—Doxorubicin—muscle cancer	0.000254	0.00117	CcSEcCtD
Rabeprazole—Hypersensitivity—Vincristine—muscle cancer	0.000254	0.00117	CcSEcCtD
Rabeprazole—CYP3A4—renal system—muscle cancer	0.000253	0.0187	CbGeAlD
Rabeprazole—Sweating—Methotrexate—muscle cancer	0.000251	0.00115	CcSEcCtD
Rabeprazole—Paraesthesia—Etoposide—muscle cancer	0.00025	0.00115	CcSEcCtD
Rabeprazole—Haematuria—Methotrexate—muscle cancer	0.00025	0.00115	CcSEcCtD
Rabeprazole—CYP1A1—vagina—muscle cancer	0.000249	0.0184	CbGeAlD
Rabeprazole—Pancreatitis—Doxorubicin—muscle cancer	0.000249	0.00115	CcSEcCtD
Rabeprazole—CYP2D6—renal system—muscle cancer	0.000249	0.0184	CbGeAlD
Rabeprazole—Dyspnoea—Etoposide—muscle cancer	0.000249	0.00114	CcSEcCtD
Rabeprazole—Somnolence—Etoposide—muscle cancer	0.000248	0.00114	CcSEcCtD
Rabeprazole—Angina pectoris—Doxorubicin—muscle cancer	0.000248	0.00114	CcSEcCtD
Rabeprazole—Epistaxis—Methotrexate—muscle cancer	0.000247	0.00114	CcSEcCtD
Rabeprazole—Asthenia—Vincristine—muscle cancer	0.000247	0.00114	CcSEcCtD
Rabeprazole—Vomiting—Dactinomycin—muscle cancer	0.000245	0.00113	CcSEcCtD
Rabeprazole—Bronchitis—Doxorubicin—muscle cancer	0.000245	0.00112	CcSEcCtD
Rabeprazole—Agranulocytosis—Methotrexate—muscle cancer	0.000244	0.00112	CcSEcCtD
Rabeprazole—Rash—Dactinomycin—muscle cancer	0.000243	0.00112	CcSEcCtD
Rabeprazole—Decreased appetite—Etoposide—muscle cancer	0.000242	0.00111	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—muscle cancer	0.000242	0.00111	CcSEcCtD
Rabeprazole—Constipation—Etoposide—muscle cancer	0.000238	0.0011	CcSEcCtD
Rabeprazole—Pain—Etoposide—muscle cancer	0.000238	0.0011	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—muscle cancer	0.000238	0.00109	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—muscle cancer	0.000238	0.00109	CcSEcCtD
Rabeprazole—Diarrhoea—Vincristine—muscle cancer	0.000236	0.00108	CcSEcCtD
Rabeprazole—Hepatitis—Methotrexate—muscle cancer	0.000235	0.00108	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—muscle cancer	0.000235	0.00108	CcSEcCtD
Rabeprazole—ABCG2—testis—muscle cancer	0.000234	0.0173	CbGeAlD
Rabeprazole—Pharyngitis—Methotrexate—muscle cancer	0.000233	0.00107	CcSEcCtD
Rabeprazole—Urinary tract disorder—Methotrexate—muscle cancer	0.000232	0.00107	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000232	0.00107	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—muscle cancer	0.000231	0.00106	CcSEcCtD
Rabeprazole—Urethral disorder—Methotrexate—muscle cancer	0.00023	0.00106	CcSEcCtD
Rabeprazole—CYP1A1—head—muscle cancer	0.00023	0.017	CbGeAlD
Rabeprazole—Weight decreased—Doxorubicin—muscle cancer	0.00023	0.00106	CcSEcCtD
Rabeprazole—Feeling abnormal—Etoposide—muscle cancer	0.00023	0.00106	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—muscle cancer	0.000229	0.00105	CcSEcCtD
Rabeprazole—Nausea—Dactinomycin—muscle cancer	0.000229	0.00105	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—muscle cancer	0.000228	0.00105	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Etoposide—muscle cancer	0.000228	0.00105	CcSEcCtD
Rabeprazole—Dizziness—Vincristine—muscle cancer	0.000228	0.00105	CcSEcCtD
Rabeprazole—Visual impairment—Methotrexate—muscle cancer	0.000227	0.00104	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000225	0.00103	CcSEcCtD
Rabeprazole—Erythema multiforme—Methotrexate—muscle cancer	0.000222	0.00102	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000222	0.00102	CcSEcCtD
Rabeprazole—Urticaria—Etoposide—muscle cancer	0.000222	0.00102	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—muscle cancer	0.000221	0.00102	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—muscle cancer	0.000221	0.00102	CcSEcCtD
Rabeprazole—Abdominal pain—Etoposide—muscle cancer	0.00022	0.00101	CcSEcCtD
Rabeprazole—Body temperature increased—Etoposide—muscle cancer	0.00022	0.00101	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—muscle cancer	0.00022	0.00101	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—muscle cancer	0.00022	0.00101	CcSEcCtD
Rabeprazole—Eye disorder—Methotrexate—muscle cancer	0.00022	0.00101	CcSEcCtD
Rabeprazole—Tinnitus—Methotrexate—muscle cancer	0.000219	0.00101	CcSEcCtD
Rabeprazole—Vomiting—Vincristine—muscle cancer	0.000219	0.00101	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—muscle cancer	0.000217	0.000999	CcSEcCtD
Rabeprazole—Rash—Vincristine—muscle cancer	0.000217	0.000998	CcSEcCtD
Rabeprazole—Dermatitis—Vincristine—muscle cancer	0.000217	0.000997	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—muscle cancer	0.000216	0.000994	CcSEcCtD
Rabeprazole—Headache—Vincristine—muscle cancer	0.000216	0.000991	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—muscle cancer	0.000214	0.000983	CcSEcCtD
Rabeprazole—Angiopathy—Methotrexate—muscle cancer	0.000213	0.00098	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—muscle cancer	0.000213	0.000978	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—muscle cancer	0.000212	0.000973	CcSEcCtD
Rabeprazole—Chills—Methotrexate—muscle cancer	0.000211	0.000969	CcSEcCtD
Rabeprazole—Alopecia—Methotrexate—muscle cancer	0.000208	0.000955	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—muscle cancer	0.000207	0.000952	CcSEcCtD
Rabeprazole—Hypersensitivity—Etoposide—muscle cancer	0.000205	0.000944	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—muscle cancer	0.000205	0.000941	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—muscle cancer	0.000205	0.000941	CcSEcCtD
Rabeprazole—Nausea—Vincristine—muscle cancer	0.000204	0.00094	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—muscle cancer	0.000204	0.000938	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—muscle cancer	0.000204	0.000936	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—muscle cancer	0.000202	0.000929	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.000201	0.000924	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—muscle cancer	0.000201	0.000922	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—muscle cancer	0.0002	0.000921	CcSEcCtD
Rabeprazole—Asthenia—Etoposide—muscle cancer	0.0002	0.000919	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—muscle cancer	0.0002	0.000917	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—muscle cancer	0.000198	0.00091	CcSEcCtD
Rabeprazole—Pruritus—Etoposide—muscle cancer	0.000197	0.000907	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—muscle cancer	0.000196	0.000902	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—muscle cancer	0.000193	0.000886	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—muscle cancer	0.000193	0.000885	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—muscle cancer	0.000191	0.000877	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—muscle cancer	0.00019	0.000874	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—muscle cancer	0.00019	0.000873	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—muscle cancer	0.00019	0.000872	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—muscle cancer	0.000189	0.000869	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—muscle cancer	0.000185	0.000849	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—muscle cancer	0.000185	0.000848	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—muscle cancer	0.000184	0.000847	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—muscle cancer	0.000184	0.000845	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—muscle cancer	0.000183	0.000842	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—muscle cancer	0.000183	0.000839	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—muscle cancer	0.000182	0.000836	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—muscle cancer	0.00018	0.000827	CcSEcCtD
Rabeprazole—Cough—Methotrexate—muscle cancer	0.000179	0.000821	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—muscle cancer	0.000177	0.000815	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—muscle cancer	0.000177	0.000815	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—muscle cancer	0.000177	0.000814	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—muscle cancer	0.000177	0.000814	CcSEcCtD
Rabeprazole—Rash—Etoposide—muscle cancer	0.000176	0.000808	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—muscle cancer	0.000176	0.000807	CcSEcCtD
Rabeprazole—Headache—Etoposide—muscle cancer	0.000175	0.000803	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—muscle cancer	0.000175	0.000803	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—muscle cancer	0.000174	0.000801	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—muscle cancer	0.000174	0.000801	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—muscle cancer	0.000174	0.000801	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—muscle cancer	0.000174	0.000799	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—muscle cancer	0.000174	0.000798	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—muscle cancer	0.000172	0.000791	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—muscle cancer	0.000172	0.000791	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—muscle cancer	0.000171	0.000788	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—muscle cancer	0.00017	0.000783	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—muscle cancer	0.000168	0.000774	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—muscle cancer	0.000167	0.000768	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—muscle cancer	0.000167	0.000768	CcSEcCtD
Rabeprazole—CYP2D6—head—muscle cancer	0.000166	0.0123	CbGeAlD
Rabeprazole—Nausea—Etoposide—muscle cancer	0.000166	0.000761	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000164	0.000756	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—muscle cancer	0.000164	0.000753	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000164	0.000752	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—muscle cancer	0.000163	0.000748	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—muscle cancer	0.000161	0.000742	CcSEcCtD
Rabeprazole—CYP2D6—testis—muscle cancer	0.000161	0.0119	CbGeAlD
Rabeprazole—Malaise—Doxorubicin—muscle cancer	0.00016	0.000734	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—muscle cancer	0.000159	0.000732	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—muscle cancer	0.000159	0.000732	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—muscle cancer	0.000159	0.00073	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—muscle cancer	0.000159	0.000729	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—muscle cancer	0.000157	0.00072	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—muscle cancer	0.000156	0.000717	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—muscle cancer	0.000156	0.000716	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—muscle cancer	0.000155	0.000711	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—muscle cancer	0.000154	0.000706	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—muscle cancer	0.000153	0.000703	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000152	0.000699	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—muscle cancer	0.000151	0.000694	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—muscle cancer	0.000151	0.000693	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—muscle cancer	0.000151	0.000693	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—muscle cancer	0.000151	0.000693	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—muscle cancer	0.00015	0.000691	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—muscle cancer	0.00015	0.000689	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—muscle cancer	0.000149	0.000685	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—muscle cancer	0.000149	0.000684	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—muscle cancer	0.000149	0.000682	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—muscle cancer	0.000148	0.000678	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—muscle cancer	0.000147	0.000676	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—muscle cancer	0.000146	0.00067	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—muscle cancer	0.000145	0.000667	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—muscle cancer	0.000145	0.000665	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000145	0.000665	CcSEcCtD
Rabeprazole—Pain—Methotrexate—muscle cancer	0.000143	0.000656	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—muscle cancer	0.000142	0.000654	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000142	0.000651	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—muscle cancer	0.000141	0.000649	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.00014	0.000643	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—muscle cancer	0.000138	0.000634	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—muscle cancer	0.000138	0.000633	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000137	0.000628	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—muscle cancer	0.000135	0.000621	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—muscle cancer	0.000133	0.00061	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—muscle cancer	0.000132	0.000607	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—muscle cancer	0.000132	0.000607	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000132	0.000606	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—muscle cancer	0.000131	0.000601	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—muscle cancer	0.00013	0.000597	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—muscle cancer	0.000129	0.000593	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—muscle cancer	0.000129	0.000591	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—muscle cancer	0.000127	0.000585	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—muscle cancer	0.000126	0.000578	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—muscle cancer	0.000124	0.000568	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—muscle cancer	0.000124	0.000568	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—muscle cancer	0.000123	0.000566	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—muscle cancer	0.00012	0.000551	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—muscle cancer	0.000119	0.000548	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000118	0.000544	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—muscle cancer	0.000118	0.000543	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—muscle cancer	0.000115	0.000528	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—muscle cancer	0.000114	0.000525	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—muscle cancer	0.000114	0.000525	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—muscle cancer	0.000114	0.000525	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—muscle cancer	0.00011	0.000508	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000107	0.00049	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—muscle cancer	0.000106	0.000488	CcSEcCtD
Rabeprazole—Rash—Methotrexate—muscle cancer	0.000105	0.000484	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—muscle cancer	0.000105	0.000484	CcSEcCtD
Rabeprazole—Headache—Methotrexate—muscle cancer	0.000105	0.000481	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—muscle cancer	0.000104	0.000477	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—muscle cancer	0.000102	0.00047	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—muscle cancer	9.92e-05	0.000456	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—muscle cancer	9.9e-05	0.000455	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—muscle cancer	9.57e-05	0.00044	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—muscle cancer	9.2e-05	0.000423	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—muscle cancer	9.12e-05	0.000419	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—muscle cancer	9.11e-05	0.000419	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—muscle cancer	9.06e-05	0.000416	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—muscle cancer	8.59e-05	0.000395	CcSEcCtD
